Abeona Therapeutics (ABEO) Share-based Compensation (2011 - 2026)

Abeona Therapeutics' Share-based Compensation history runs 16 years deep, the most recent figure standing at $1.0 million for Q1 2026.

• On a quarterly basis, Share-based Compensation fell 62.98% year-over-year to $1.0 million in Q1 2026; TTM through Mar 2026 was $1.0 million, a 87.15% decrease from a year earlier, with the FY2025 full-year figure at $13.7 million, up 106.7% from the prior year.
• Share-based Compensation declined to $1.0 million in Q1 2026 per ABEO's latest filing, from $5.5 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $5.5 million in Q4 2025 and bottomed at -$2.8 million in Q4 2023.
• The 5-year median for Share-based Compensation is $1.3 million (2024), against an average of $1.5 million.
• Across the five-year window, Share-based Compensation slumped 440.34% in 2023 and jumped 180.31% in 2025, its largest moves.
• Year by year, Share-based Compensation stood at $833000.0 in 2022, then slumped by 440.34% to -$2.8 million in 2023, then soared by 168.96% to $2.0 million in 2024, then soared by 180.31% to $5.5 million in 2025, then tumbled by 81.75% to $1.0 million in 2026.
• Per Business Quant, the three latest ABEO Share-based Compensation figures stand at $1.0 million (Q1 2026), $5.5 million (Q4 2025), and $2.7 million (Q3 2025).